(Q43179684)

15 November 2017

title

Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes (English)

1 reference

15 November 2017

1 reference

J Wu

1

1 reference

15 November 2017

F Zhang

2

1 reference

15 November 2017

F Fang

3

1 reference

15 November 2017

H Chang

4

1 reference

15 November 2017

F Wang

5

1 reference

15 November 2017

Z Yang

6

1 reference

15 November 2017

B Sun

7

1 reference

15 November 2017

Z Chen

8

1 reference

15 November 2017

language of work or name

English

0 references

publication date

29 January 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

28

1 reference

15 November 2017

issue

15

1 reference

15 November 2017

page(s)

2775-2781

1 reference

Changing epidemiology and ecology of highly pathogenic avian H5N1 influenza viruses.

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

H5N1 Virus Attachment to Lower Respiratory Tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Acquired defect in interleukin-2 production in patients with type I diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Phagocytotic activity of monocytes from diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Reduced immune response to hepatitis B vaccine in children with insulin dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Infections and diabetes: mechanisms and prospects for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Quantifying the risk of infectious diseases for people with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

The reactive D-glucopyranose moiety of streptozotocin is responsible for activation of macrophages and subsequent stimulation of CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Systemic and local immune responses after parenteral influenza vaccination in juvenile diabetic patients and healthy controls: results from a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

Reduced hospitalizations and death associated with influenza vaccination among patients with and without diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.01.037

10.1016/J.VACCINE.2010.01.037

7 January 2021

Identifiers

DOI

1 reference

15 November 2017

1 reference